CUSIP 90466Y202COM NEWUNCYQ4 2025
11 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vivo Capital, LLC | 1.79M | $10.33M |
| 2 | Millennium Management LLC | 1.01M | $5.86M |
| 3 | Octagon Capital Advisors LP | 1.00M | $5.77M |
| 4 | Nantahala Capital Management, LLC | 939.2K | $5.42M |
| 5 | Great Point Partners LLC | 796.6K | $4.60M |
| 6 | Vanguard Group Inc | 788.6K | $4.55M |
| 7 | Logos Global Management LP | 473.6K | $2.73M |
| 8 | Citadel Advisors LLC | 258.3K | $1.49M |
| 9 |
| 4 | Jan 23, 2026 | Integrated Core Strategies (Us) LLC | 13G | 11.0% | 1.17M | SEC |
| 5 | Nov 14, 2025 | Great Point Partners, LLC | 13G/A | 4.5% | 796.6K | SEC |
| 6 | Nov 14, 2025 | Ra Capital Management, L.P. | 13G/A | 9.9% | 1.96M | SEC |
| 7 | Nov 14, 2025 | Octagon Capital Advisors LP | 13G/A | 5.7% | 1.00M | SEC |
| 8 | Nov 14, 2025 | Vivo Opportunity Fund Holdings, L.P. | 13G/A | 10.0% | 6.10M | SEC |
| 9 | Aug 14, 2025 | Great Point Partners, LLC | 13G/A | 6.2% | 796.6K | SEC |
| 10 | Aug 14, 2025 | Biotechnology Value Fund L P | 13G/A | 10.0% | 1.42M | SEC |
See the full Schedule 13D/13G history for Unicycive Therapeutics Inc.
Unlock full history| Cantor Fitzgerald, L. P. |
| 200.0K |
| $1.15M |
| 10 | Geode Capital Management, LLC | 171.3K | $989.2K |